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Abstract 
Background: The Clinical Frailty Scale (CFS) is frequently used to measure frailty in critically ill adults. There is wide 
variation in the approach to analysing the relationship between the CFS score and mortality after admission to the 
ICU. This study aimed to evaluate the influence of modelling approach on the association between the CFS score and 
short‑term mortality and quantify the prognostic value of frailty in this context.
Methods: We analysed data from two multicentre prospective cohort studies which enrolled intensive care unit 
patients ≥ 80 years old in 26 countries. The primary outcome was mortality within 30‑days from admission to the ICU. 
Logistic regression models for both ICU and 30‑day mortality included the CFS score as either a categorical, continu‑
ous or dichotomous variable and were adjusted for patient’s age, sex, reason for admission to the ICU, and admission 
Sequential Organ Failure Assessment score.
Results: The median age in the sample of 7487 consecutive patients was 84 years (IQR 81–87). The highest fraction 
of new prognostic information from frailty in the context of 30‑day mortality was observed when the CFS score was 
treated as either a categorical variable using all original levels of frailty or a nonlinear continuous variable and was 
equal to 9% using these modelling approaches (p < 0.001). The relationship between the CFS score and mortality was 
nonlinear (p < 0.01).
Conclusion: Knowledge about a patient’s frailty status adds a substantial amount of new prognostic information 
at the moment of admission to the ICU. Arbitrary simplification of the CFS score into fewer groups than originally 
intended leads to a loss of information and should be avoided.
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Introduction
Progressive ageing is one of the leading issues in contem-
porary critical care [1]. Patients ≥ 80  years old account 
for 10 to 20% of all admissions to the intensive care unit 
(ICU) , and this number is projected to increase sharply 
over next 3  decades [2]. The growing proportion of 
older adults admitted to ICUs will require substantial 
resources, at the same time as many countries are already 
facing a shortage of ICU beds [3–5]. The high mortality in 
the population of older critically ill adults has prompted 
researchers to identify factors which could help improve 
the allocation of scarce intensive care resources and alle-
viate the suffering of patients and their families facing an 
uncertain prognosis [6].
Among many geriatric syndromes, frailty may be 
the most useful concept in the context of severe illness 
requiring admission to the ICU [7]. Frailty is defined as 
a clinically recognisable state of increased vulnerability 
resulting from ageing-associated decline in reserve and 
function across multiple physiologic systems such that 
the ability to cope with acute stressors is compromised 
[8, 9]. The presence of frailty is associated with increased 
morbidity in older adults, and the chances of 30-day sur-
vival after admission to the ICU are significantly lower in 
frail patients compared to their fit counterparts [10–12].
The Clinical Frailty Scale (CFS) is a widely used 
frailty assessment tool which has gained recognition in 
a variety of clinical settings over the past decade [13]. 
Unlike many other instruments describing the degree 
of frailty, the CFS score was shown to be reliable in the 
highly dynamic context of acute admission to the ICU 
in patients ≥ 80 years old  [14, 15]. Frailty is most often 
defined as a CFS score greater than or equal to 5, with 
a CFS score of 4 labelled as pre-frailty (vulnerability, liv-
ing with mild frailty) and CFS scores between 1 and 3 
referred to as fitness. However, recent evidence shows 
that no clinically relevant worsening in prognosis occurs 
at the transition of pre-frailty to frailty, suggesting that 
such categorisation does not accurately reflect the rela-
tionship between the CFS and patients’ outcomes [16]. 
Analysing the CFS score as a continuous variable pro-
vides a solution to the problem of arbitrary stratification 
of patients according to pre-defined thresholds, but at the 
same time makes a strong assumption that the risk of an 
outcome of interest increases linearly with increasing lev-
els of frailty.
The objective of this study was to establish the opti-
mal approach to analysing the association between 
pre-admission frailty and short-term mortality by means 
of the CFS score using a large sample of very old inten-
sive care unit patients (VIPs) acutely admitted to the ICU 
within two international prospective cohort studies. We 
aimed to formally test the hypothesis that the association 
between frailty and ICU mortality is linear, describe the 
risk of ICU mortality across the entire spectrum of CFS 
scores, and quantify the added prognostic value of frailty 
in patients ≥ 80 years old.
Methods
Study design and patient population
The Very Old Intensive Care Patient (VIP1 and VIP2) 
studies were prospective, multicentre studies registered 
on ClinicalTrials.gov (ID: NCT03134807, NCT03370692, 
respectively) [7, 11]. Both studies included patients 
aged 80 years or older admitted to the ICU with no spe-
cific exclusion criteria, and all acutely admitted patients 
were eligible for this analysis. Sources of data, meth-
ods of measurement, and results of analyses performed 
previously on these data were described in detail else-
where [7, 11]. In summary, all participating ICUs were 
asked to include 20 consecutive VIPs over a 3-month 
(VIP1) or 6-month (VIP2) period. Patients’ vital status 
within 30  days of admission to the ICU was assessed 
by inspecting hospital records, direct contact with the 
patient, or checking a national registry. Patients were 
recruited between October 2016 and February 2017 
(VIP1 study) and between May 2018 and May 2019 
(VIP2 study). All procedures performed in studies involv-
ing human participants were in accordance with the 
ethical standards of the institutional and/or national 
research committee and with the 1964 Declaration of 
Helsinki and its later amendments or comparable ethi-
cal standards. Each country had a national coordinator 
responsible for application for national or regional ethi-
cal and regulatory study approval. Institutional research 
ethic board approval was obtained from each study site. 
Some countries were allowed to recruit patients with-
out prior written informed consent, while others had 
to collect informed consent from patient or their legal 
representative.
Outcomes and procedure
Outcomes in this study were ICU mortality and 30-day 
mortality. Demographic data which included patients’ 
age, sex, and reason for admission to the ICU were col-
lected in each eligible participant. Severity of organ 
Trial registration NCT03134807 (VIP1), NCT03370692 (VIP2)
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dysfunction within the first 24  h after admission to the 
ICU was assessed using the cumulative Sequential Organ 
Failure Assessment (SOFA) score (from 0 to 24 points 
assigned in the cardiovascular, respiratory, renal, neu-
rologic, hepatic, and coagulation system with increasing 
number of points corresponding to more severe organ 
failure; the highest summary score observed within the 
first 24 h was reported) [17]. Necessity for organ support 
(vasoactive drugs, intubation and mechanical ventilation, 
and renal replacement therapy) was documented during 
the ICU stay.
We used the Clinical Frailty Scale (CFS) to describe 
patients’ frailty before admission to the hospital with 9 
possible classes from very fit prior to the acute illness to 
terminally ill [18]. Information necessary to perform this 
assessment was given by patients or proxy or obtained 
from patient records. The CFS visual along with a sim-
ple description was used with permission. We performed 
separate analyses using the 8-point variant of the scale 
(from fit to very severely frail) and the 9-point scale, 
where patients in the last category are not expected to 
survive more than 6  months but are not otherwise evi-
dently frail. Primary analyses were based on the 8-point 
version of this tool [16].
Statistical analysis
We used the likelihood ratio test to answer the ques-
tion whether frailty adds new information about the risk 
of death in the ICU and at 30-day follow-up to baseline 
variables available at admission in a logistic regression 
model. (i.e. age, sex, reasons for admission to the ICU, 
and the SOFA score) [19]. Statistical models were built 
based on clinical rationale and utilised all baseline vari-
ables available in the merged dataset. We decided to per-
form a complete-case analysis as the overall amount of 
missing data was relatively small. A detailed inspection of 
missing data was performed and presented in Additional 
file 1.
We used five different approaches to analysing frailty in 
logistic regression models:
1. Categorical: we modelled the CFS score as a categori-
cal variable using all original levels (i.e. 8 or 9 catego-
ries in the main and supplementary analysis, respec-
tively).
2. Linear: CFS was treated as a continuous variable 
without allowing for nonlinearities in the log-odds 
for mortality (i.e. a standard technique used as a 
default setting in statistical software).
3. Nonlinear: the relationship between the CFS and the 
outcome was modelled using restricted cubic splines 
with five knots at the 5th, 27.5th, 50th, 72.5th, and 
95th quantile of the distribution of CFS, thus allow-
ing for nonlinear relationships and avoiding the 
known problems resulting from categorization of 
continuous variables (e.g. loss of statistical power, 
increased risk of false positive findings, underestima-
tion of variation in outcomes between groups) [20]. 
Wald tests were used to assess departures from lin-
earity of log-odds.
4. Simplified grouping: we labelled patients as fit 
(CFS < 4), pre-frail (CFS = 4), or frail (CFS ≥ 5) and 
constructed the model using such created categorical 
variable with three levels.
5. Dichotomisation: we defined frailty using a single 
threshold (CFS ≥ 5) and included a binary indicator 
of patient’s frailty in the model.
The reference category for calculating odds ratios 
(ORs) was CFS = 1 for the categorical, linear, and nonlin-
ear approach. Simplified grouping and dichotomisation 
used CFS < 4 and CFS < 5 as a reference to calculate ORs, 
respectively.
Age was modelled using restricted cubic splines with 
four knots at the 5th, 35th, 65th, and 95th quantile of its 
distribution in all analyses. We summarized the added 
prognostic value of frailty as the fraction of new informa-
tion (proportion of explainable variation that is explained 
by frailty or ratio of variances of predicted values before 
and after adding frailty to the model containing only 
baseline variables described above) [19]. Descriptive 
statistics on baseline variables are presented as median 
(interquartile range [IQR]) or count and percentage. 
All analyses were performed using R version 3.6.0 (R 
Project).
Results
The combined number of acutely admitted patients in 
both the VIP 1 and VIP 2 studies was equal to 8173. The 
median number of subjects recruited per country was 
166 (IQR 33–482), and the two most actively recruiting 
countries were UK (1619) and France (971). Survival sta-
tus within 30 days from admission to the ICU was known 
in 94.5% of the patients, and 99.5% of the patients had 
complete data on ICU survival. Among patients whose 
survival status was known, 96.9% had complete data on 
all remaining variables. Patterns of missing data as well as 
a comparison of patients with complete and incomplete 
data on survival status are provided in Additional file 1: 
Figures S1–S3 and Tables S1 and S2.
Descriptive statistics, overall and among different cate-
gories of the CFS score of the analysed sample (n = 7487), 
are presented in Table  1. Patients classified as very frail 
(CFS = 8) and terminally ill (CFS = 9) had the highest 
SOFA scores and the highest incidence of vasoactive 
drugs and mechanical ventilation initiation compared 
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to participants with lower CFS scores. The length of stay 
was by far the longest in very frail patients who survived 
until discharge from the ICU.
Results from both univariate (Additional file 1: Figure 
S4) and multivariable logistic regression models provided 
evidence that the relationship between the CFS score and 
mortality within 30 days is not linear (Fig. 1, Additional 
file 1: Figure S5).
The OR for ICU mortality was statistically significantly 
different from unity at a CFS score of 6 using both the 
categorical and nonlinear modelling approach based on 
restricted cubic splines. In case of 30-day mortality, an 
apparent increase in the odds of death at a CFS score 
equal to 6 was also apparent, though the lower bound-
ary of the 95% confidence interval (CI) surpassed unity 
already at a CFS score of 4 and 5 using the categorical and 
nonlinear approach respectively. Evidence that vulner-
ability (CFS 4 vs. CFS < 4) is associated with an increased 
mortality was sufficient only in 30-day follow-up.
The magnitude of the estimated effect of frailty on 
mortality was greater in the 30-day mortality logistic 
regression compared to the ICU mortality model, and the 
slope of increase in the odds of death was steeper with 
increasing CFS scores. When patients were dichotomised 
as either frail (CFS ≥ 5) or not frail (CFS < 5), frailty was 
associated with an OR for mortality in the ICU and 
within 30 days equal to 1.22 (95% CI 1.09–1.36) and 1.50 
(95% CI 1.35–1.66), respectively.
The fraction of new information from the categorical 
CFS score over and above data on patient’s age, sex, rea-
son for admission to the ICU, and the SOFA score across 
different modelling strategies is shown in Table 2.
Categorical and nonlinear modelling of the CFS was 
associated with the highest information yield, and 
dichotomising patients into either frail or not frail led 
to the greatest loss of information in both the ICU and 
30-day mortality models. Likelihood ratio tests indicated 
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Modelling approach Categorisation Linear Nonlinear Simplified grouping
Fig. 1 The impact of modelling approach on the association between frailty and short‑term mortality. Simplified grouping used CFS < 4 as a 
reference, with vulnerability defined as a CFS = 4 and frailty as a CFS ≥ 5; CFS = 1 was used as a reference in the three other modelling approaches 
shown in the figure. Odds ratios obtained after dichotomisation of the CFS score are described in the text. The relationship between the CFS score 
and mortality was nonlinear in both models (p values < 0.01). Adjusted for age, sex, reason for admission to the ICU, and admission SOFA score
Table 2 Fraction of new prognostic information from including frailty in the model
Fraction of new information p value (likelihood ratio test)
ICU mortality model (%) 30-day mortality model (%) ICU mortality model 30-day 
mortality 
model
Categorisation 3 9  < 0.001 < 0.001
Linear 2 8 < 0.001 < 0.001
Nonlinear 3 9 < 0.001 < 0.001
Simplified grouping 1 6 0.002 < 0.001
Dichotomisation 1 5 < 0.001 < 0.001
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fit in all cases (all p values < 0.01). Results of sensitivity 
analyses based on the 9-point version of the CFS score 
are presented in Additional file 1: Figures S6 and S7 and 
Table S3. The adjusted probability of death across differ-
ent CFS scores is shown in Fig. 2.
Discussion
We found that the relationship between frailty and 
30-day mortality is not linear in patients ≥ 80  years old 
acutely admitted to the ICU. Using separate logistic 
regression models, we showed that the prognostic con-
tribution of frailty was larger in case of 30-day mortality 
compared to ICU mortality. The association between the 
CFS score and mortality was highly dependent on how 
the score was handled in statistical analysis. Defining 
frailty as a CFS ≥ 5 led to a substantial underestimation 
of the odds of death for patients whose CFS score was 
equal to 7 or 8 and resulted in a loss of more than 50% of 
new prognostic information compared to using all levels 
of the 9-point Clinical Frailty Scale. The categorical and 
nonlinear approach to modelling frailty best captured the 
relationship between the CFS score and mortality and 
should be preferred over the other inspected methods of 
analysing frailty in future studies evaluating mortality in 
this population of patients.
A scoping review of the utilisation of the CFS score in 
the literature showed that 40 out of 58 papers (68.9%) 
using a threshold value of the CFS score to define frailty 
were based on a cut-off of 5, with 25.9% of publica-
tions based on a threshold of 4 and only 3.4% labelling 
patients with a CFS score ≥ 6 as frail [13]. Results of large 
registry-based study describing differences in outcomes 
of critically ill patients with pneumonia depending on 
their level of frailty conducted recently did not support 
a CFS ≥ 5 threshold to guide ICU admission [16]. The 
authors noted little difference between vulnerable, mild, 
and moderate frailty categories in terms of the adjusted 
risk of mortality. Another interesting finding was that the 
CFS score behaved differently in patients ≥ 65 years old 
than in younger adults. The observed increase in mortal-
ity with increasing CFS scores was apparently linear in 
the whole cohort and gradually accelerating in the older 
subgroup.
Results from a combined database of patients 
≥ 80 years old enrolled in the VIP1 and VIP2 studies cor-
roborate the results of Darvall and colleagues in the sense 
that there is little evidence of a difference in outcomes 
between patients whose CFS score ranges between 1 
and 5 after adjustment for basic patient characteristics 
and that a threshold value of CFS ≥ 5 is not justified 
as a marker of frailty in the context of mortality within 
30  days from admission to the ICU. Possibly thanks to 
the larger sample size, we were able to confirm that a CFS 
score of 6, not 7, is already associated with an increased 
risk of death. This minor discrepancy may either reflect 
a higher statistical power in current analyses or stem 
from the fact that our study enrolled a broad spectrum 
of patients admitted to the ICU and was not focused 
exclusively on patients with pneumonia. Unlike Darvall 
and colleagues, we found evidence that the relationship 
between frailty as described by the CFS score and mortal-
ity is nonlinear, which is in line with previous theoretical 
considerations about the expected character of increase 
in mortality with accumulating deficits [21].
The association between frailty and mortality was more 
pronounced in 30-day follow-up than when assessed up 
to the moment of death or discharge from the ICU. Sev-
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Modelling approach Categorisation Linear Nonlinear
Fig. 2 The impact of modelling approach on the model‑calculated risk of death. Adjusted probabilities displayed for an 84‑year‑old male admitted 
due to respiratory reasons with a SOFA score equal to 7
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explanation is that despite surviving the acute phase of 
critical illness, frail patients ultimately reach a point of 
exhaustion of their functional reserves and deteriorate as 
a result of the initial stressor. It needs to be highlighted 
that despite not finding a clear association between lower 
CFS scores and mortality, it is reasonable to believe that 
patients with wild milder frailty fare worse in terms of 
functional outcomes and quality of life in long-term 
observation after being admitted to the ICU [22–24].
A more general claim that can be made based on the 
results of our study is that any attempts to define frailty 
as a condition that is either present or absent are destined 
to fail. Despite the conceptual ease and convenience of 
treating patients as fit or frail both from a researcher’s 
and practicing clinician’s perspective, we must not forget 
that frailty is a continuum. Loss of prognostic informa-
tion is inevitable whenever arbitrary grouping of patients 
takes place, particularly when trying to transform a 
robust score such as the CFS into a binary screening 
tool. In practice, decisions such as whether to admit a 
patient to the ICU or not have to be made at some point 
based on a context-specific threshold [25]. Nevertheless, 
efforts should be made to present the clinician with the 
most accurate and comprehensive picture of the patient’s 
prospects and let her or him utilise the full potential of 
analysed data (i.e. the probability of an event based on 
a granular assessment of patient’s frailty, not merely the 
information whether an arbitrary CFS threshold had 
been crossed).
Even with the best available estimates of prognosis 
based on robust statistical models, the decision-making 
process in the context of intensive care provision for 
older adults will remain a multidimensional challenge 
shaped by a plethora of contextual and temporal factors 
that are difficult to capture in a set of static regression 
coefficients. The evidence to inform risk–benefit assess-
ment on admission to the ICU and further into the course 
of critical illness in vulnerable populations is accumulat-
ing, with more detailed data on functional outcomes in 
long-term observation to come in the near future. It is in 
our patients’ interest that we transform this evidence into 
policies efficiently, understanding the consequences of 
choices made at the stage of data analysis. If the adjusted 
probability of death within 30 days from admission to the 
ICU with a CFS score of 5, 6, and 7 is estimated at 39%, 
47%, and 55%, as illustrated in our study, where should 
we draw a demarcation line for prognostically important 
frailty, if at all? Before attempting to answer this question, 
one must first acknowledge the variability in outcomes 
between particular categories of the CFS score that arbi-
trary cut-offs unfortunately discard altogether.
In observational studies attempting to adjust for con-
founding by frailty or quantify its impact on outcomes, 
using the CFS score as either a categorical variable 
comprising all the original levels or a continuous vari-
able while allowing for nonlinearities in the estimated 
effect of frailty on outcome is likely to lead to the least 
amount of residual confounding and improve inference 
compared to simpler approaches to modelling frailty 
such as dichotomisation or forced linearity [26, 27].
This study has several limitations. First, ICUs 
included in the VIP1 and VIP2 studies participated 
voluntarily and were not sampled at random. Second, 
informed consent from patients or their legal repre-
sentatives had to be collected before enrolment in most 
participating countries due to national differences in 
data protection regulations which may affect the gen-
eralizability of our results to the entire population of 
acutely admitted patients. Third, a small fraction of 
patients had still been hospitalized in the ICU after 
30  days from admission, thus increasing the uncer-
tainty about actual mortality rates observed within 
our study. Fourth, the pragmatic nature of the VIP1 
and VIP2 studies precluded routine collection of more 
detailed data on patients’ chronic health status prior to 
admission to the ICU, potentially leaving a substantial 
part of variation in the modelled outcome unexplained 
and possibly inflating the fraction of new prognostic 
information from frailty. Fifth, we focused exclusively 
on mortality and did not trace post-discharge health 
trajectories of VIPs (e.g. in terms of functional capacity, 
cognitive impairment, and mental health) in long-term 
observation.
The strength of our study is that we prospectively 
enrolled a large, contemporary cohort of consecutive 
patients ≥ 80  years old admitted to ICUs in 26 coun-
tries for various reasons. The collection of standardized 
data from nearly 8000 VIPs and the use of contempo-
rary statistical modelling techniques provided an ample 
opportunity to answer the question about the opti-
mal approach to analysing frailty in this population of 
patients.
Conclusions
In conclusion, frailty contributes up to 9% of new prog-
nostic information about 30-day mortality in the pres-
ence of basic patient characteristics. We showed that the 
increase in the risk of death within 30 days from admis-
sion to the ICU is mild at best in lower categories of the 
CFS score and more abrupt in patients whose CFS score 
is equal to 6 or greater. To accurately describe the rela-
tionship between frailty and short-term mortality, future 
studies should analyse the CFS score either as a nonlinear 
continuous variable or a categorical variable while retain-
ing all the original levels of frailty.
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